XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A Accounts Payable

As of the most recent data (March 2026), XOMAP shows a accounts payable of $3.5M. That compares with $2.3M in the prior-year period — up 52.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, XOMAP's accounts payable is now $3.5M (was $2.3M) — a 52.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A is outperforming or lagging.

Tracking XOMAP's accounts payable over time shows whether XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A is scaling, shrinking, or reshaping that part of the business. The current reading is $3.5M That compares with $2.3M in the prior-year period — up 52.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $3.5M) with ownership activity and broader fundamentals.

XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A's accounts payable is $3.5M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.